Bone marrow stromal cells for immunoprotection of transplanted neural stem cells
AssigneeCognate Therapeutics, Inc.
InventorKevin McIntosh
Life of this patent
Estimating the term…
Abstract
The present invention encompasses methods and compositions for reducing an immune response to a transplant recipient receiving NSCs by treating said recipient with an amount of bone marrow stromal effective to reduce or inhibit host rejection of the NSCs.
Claims21
A method of treating a transplant recipient, wherein said transplant is a neural stem cell (NSC), to reduce in said recipient an immune response of effector cells against an alloantigen to said effector cells, the method comprising;
- administering to a transplant recipient, bone marrow stromal cells in an amount effective to reduce an immune response of effector cells against an alloantigen to said effector cells, whereby in the transplant recipient said effector cells have a reduced immune response against said alloantigen.
A method for treating a transplant recipient, wherein said transplant is a neural stem cell (NSC), to reduce in said recipient an immune response of effector cells against an alloantigen to the effector cells, comprising:
- transplanting to a transplant recipient NSCs with bone marrow stromal cells in an amount effective to reduce an immune response of effector cells against an alloantigen to the effector cells, whereby in the transplant recipient the effector cells have a reduced immune response against the alloantigen.
Dependencies are inferred from the claim text.